The veterinary diagnostics market is projected to grow from USD 4.04 billion in 2022 to USD 7.27 billion by 2030, driven by the increasing prevalence of zoonotic diseases and the rising adoption of ...

Revvity, Inc. RVTY is well-positioned for growth in the coming quarters, thanks to its strong product portfolio. The optimism ...

Thermo Fisher Scientific Inc.’s TMO recent slew of strategic acquisitions reflects its ongoing commitment to sustainable long-term growth. End markets play an important role as well, bolstering Thermo ...

This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics ...

Ausria, a radioimmunoassay test to detect serum hepatitis, was launched in 1972 and marked the beginning of Abbott's immunodiagnostics business. A year later, the Abbott Diagnostics Division was ...

At close: 28 March at 4:00:02 pm GMT-4 ...